 10. Systemic anticancer treatment including investigational agents or radiotherapy 2 weeks before the first dose of study treatment 4 weeks for antibody-based therapy including unconjugated antibody, antibody-drug conjugate, and bi-specific T-cell engager agents; 8 weeks for cell-based therapy or antitumor vaccine or have not recovered from acute toxic effects from prior chemotherapy and radiotherapy. 